The obtained results resemble the results from the analysis using previous models, further highlighting the role of GSTM1 and GSTP1 polymorphisms as possible determinants of mortality risk in patients with colorectal cancer (HR 1.89, p = 0.001 and HR 1.50, p = 0.046, respectively). This evidence concerns the gene GSTM1 and colorectal cancer.